The query will not be unreasonable. GLP-1 medicines produce vital weight reduction. Weight reduction, by definition, includes shedding some muscle. So the priority that lively individuals have when contemplating Mounjaro or Wegovy is legit: what occurs to the muscle you’ve got spent months or years constructing?
The quick reply, supported by DXA physique composition knowledge from scientific trials, is which you can keep and construct muscle on GLP-1 medicines, however it requires deliberate effort. The medicines don’t defend muscle routinely. Resistance coaching and enough protein consumption do. What the information clarifies is what the lean mass image truly seems to be like, the place the variations between tirzepatide and semaglutide sit, and what the sensible coaching and diet response must be.
Resistance coaching is probably the most evidence-supported intervention for preserving and constructing lean mass throughout GLP-1 therapy. The sign to protect muscle comes from progressive mechanical loading, not from the remedy itself.
What “lean mass loss” truly means on GLP-1s
A standard false impression is that lean mass loss on GLP-1 medicines is uncommon or a drug-specific facet impact. It’s neither. Each vital weight reduction intervention, whether or not dietary restriction, bariatric surgical procedure, or remedy, produces a mix of fats and lean mass loss.
The physiological purpose is easy: a lighter physique requires much less structural assist, so some lean tissue is launched as a part of the adaptive reworking that accompanies main weight discount.
The SURMOUNT-1 DXA substudy, revealed in Diabetes, Weight problems and Metabolism in February 2025 (Look et al.), assessed physique composition in 124 tirzepatide-treated members utilizing dual-energy X-ray absorptiometry (DXA) at baseline and at 72 weeks. The information produced a transparent image: whole weight fell 21.3%, fats mass fell 33.9%, and lean mass fell 10.9%. Of the whole weight misplaced, roughly 75% was fats mass, and 25% was lean mass. These proportions held persistently throughout subgroups by age, intercourse, and diploma of weight reduction.
The 25% lean fraction is per what’s seen throughout different weight reduction modalities, together with bariatric surgical procedure and calorie-restricted food plan. Tirzepatide doesn’t produce disproportionate lean loss. The fat-to-lean ratio of weight misplaced is corresponding to different established approaches.
SURMOUNT-1 DXA physique composition knowledge at 72 weeks. Fats mass fell 33.9% whereas lean mass fell 10.9%. The ratio of fats to lean loss is corresponding to different weight reduction interventions, together with bariatric surgical procedure.
The tirzepatide versus semaglutide lean mass distinction
For lively individuals selecting between the 2 medicines, the physique composition distinction issues. The information right here is extra nuanced than is commonly reported.
Proportional lean loss: tirzepatide is healthier
The STEP-1 DXA data for semaglutide, as reported in a 2025 PMC case sequence, confirmed lean mass accounting for roughly 40% of whole weight misplaced, in comparison with 25-26% with tirzepatide in SURMOUNT-1. On a proportional foundation, tirzepatide produces a extra favorable fat-to-lean loss ratio. That is attributed to its twin GIP and GLP-1 receptor activation, with GIP signaling believed to have a muscle-protective impact.
Absolute lean loss: the image is extra sophisticated
A big real-world evaluation revealed on medRxiv in April 2026 analyzed physique composition knowledge from 670,422 first-episode GLP-1 sufferers throughout 12 months, together with 7,965 with paired pre- and post-treatment measurements. The findings confirmed tirzepatide was related to larger relative lean physique mass loss than semaglutide at each measured time level, with extra LBM losses of 1.1%, 1.5%, 1.3%, and a couple of.0% at 3, 6, 9, and 12 months, respectively.
The reason is arithmetic reasonably than pharmacological. Tirzepatide drives roughly 47% extra whole weight reduction than semaglutide (20.2% vs 13.7% in SURMOUNT-5). When the identical proportion of lean mass is misplaced from a bigger whole weight reduction, absolutely the quantity of lean mass misplaced is larger. The actual-world evaluation additionally recognized a “Depletive GLP-1 metabotype” (larger than 20% whole physique weight reduction with larger than 5% LBM loss) in 10.3% of tirzepatide customers versus 6.7% of semaglutide customers. For extremely lively people who find themselves already lean, this distinction is price understanding earlier than beginning therapy.
What This Means for Coaching
The lean mass knowledge doesn’t imply GLP-1 medicines must be prevented by lively individuals. It means the protecting work that resistance coaching and protein do turns into extra necessary, not much less, throughout therapy.
Resistance coaching: the evidence-supported intervention
Resistance coaching supplies the first stimulus for muscle protein synthesis. It indicators the physique to retain and construct muscle no matter whether or not a calorie deficit is current. A 2025 systematic review published in PMC confirmed that tirzepatide promotes substantial weight reduction primarily by means of fats mass discount whereas preserving lean mass, and that diet and bodily exercise can mitigate lean mass loss additional.
For GLP-1 customers who’re at present coaching, the sensible steering is straightforward: keep your resistance coaching frequency and don’t scale back quantity considerably because of decrease vitality consumption. Two to 3 periods per week of compound resistance coaching (squats, deadlifts, rows, urgent actions) supplies the mechanical sign that tells your physique to retain muscle even throughout a calorie deficit.
For individuals who haven’t been resistance coaching and are beginning GLP-1 therapy, starting a structured power routine on the identical time is among the highest-value modifications you can also make. You’ll not solely scale back the proportion of lean mass misplaced throughout therapy, however additionally, you will doubtless find yourself with higher muscle high quality and purposeful power than earlier than therapy, as a result of the fats you lose improves the ratio of muscle to whole physique mass.
Protein: the numerical goal that issues
The American Journal of Clinical Nutrition recommends 1.2 to 1.6g of protein per kilogram of physique weight per day throughout lively weight reduction to protect lean mass. For people who find themselves resistance coaching, the proof factors to 1.6 to 2.2g/kg/day as a extra applicable goal, with some analysis supporting as much as 2.4g/kg throughout aggressive calorie restriction. For a 90kg lively individual, this implies 144 to 198g of protein per day.
On GLP-1 therapy, the place urge for food is considerably decreased, hitting protein targets requires deliberate planning. The sensible method is to construct meals round protein-first: eat the protein portion of each meal earlier than anything, in order that if urge for food cuts off early, you’ve got nonetheless hit probably the most nutritionally important factor.
Excessive-protein meals which can be simple to eat in smaller parts are significantly priceless: Greek yogurt, eggs, cottage cheese, canned fish, lentils, and protein shakes for days when strong meals urge for food may be very low.
Are you able to truly construct muscle on GLP-1 medicines?
Sure, in case you are resistance coaching and consuming adequate protein. The research on which this query relies upon aren’t large-scale randomized managed trials (these haven’t been performed), however the mechanistic case is sound and per what we learn about muscle protein synthesis.
A 2025 case sequence revealed in PMC (SAGE Open Medicine) reported three sufferers who prioritized lean tissue preservation methods throughout semaglutide or tirzepatide therapy and achieved lean mass preservation considerably higher than trial benchmarks: one affected person misplaced solely 8% of whole weight as lean mass, versus the trial common of 26% to 40%.
The calorie deficit required for weight reduction does make hypertrophy (web muscle acquire) harder. To construct new muscle, you usually want both a calorie surplus or at minimal upkeep energy, neither of which applies throughout lively weight reduction.
The achievable goal on GLP-1 therapy is lean mass preservation reasonably than web muscle acquire. Meaning ending therapy with the identical absolute quantity of muscle you began with, despite the fact that you weigh much less total.
Provided that this additionally means your physique fats proportion has fallen considerably, the sensible consequence is a meaningfully higher physique and higher well being markers than earlier than.
Retatrutide and the subsequent technology of physique composition knowledge
The triple agonist retatrutide (GLP-1, GIP, and glucagon receptor activation) is at present in section 3 trials within the UK, with the primary trial finishing in December 2025. Part 2 knowledge confirmed 24.2% weight reduction at 48 weeks (12mg dose), with lean mass loss proportions much like tirzepatide and semaglutide within the same-class section 2 trial.
The glucagon receptor part of retatrutide is particularly related to physique composition as a result of glucagon stimulates vitality expenditure and fats oxidation, theoretically enhancing the fat-to-lean ratio of weight reduction.
Early section 2 knowledge confirmed 26.1% whole physique fats mass misplaced in a single trial of individuals with sort 2 diabetes, with muscle loss proportions much like different GLP-1 medicines. Voy’s retatrutide body composition analysis covers the place triple agonists match relative to present GLP-1 medicines for lively individuals.
Whether or not retatrutide will show meaningfully higher for lean mass preservation than tirzepatide stays to be decided by the section 3 knowledge, the glucagon mechanism is promising in concept, however the present knowledge doesn’t but reveal a transparent benefit over tirzepatide’s dual-agonist lean mass efficiency.
The sensible protocol for lively individuals on GLP-1s
That is the evidence-supported method for lively individuals beginning Mounjaro or Wegovy:
Coaching
- Preserve resistance coaching frequency: At minimal two periods per week. Three to 4, if doable. Compound lifts that load the most important muscle teams (squats, deadlifts, horizontal and vertical rows, urgent actions).
- Don’t dramatically scale back coaching quantity: Decrease vitality consumption doesn’t imply decrease coaching ought to comply with routinely. Many individuals discover that coaching efficiency is comparatively properly maintained on GLP-1 therapy, significantly after the preliminary adjustment interval.
- Prioritize restoration: Sufficient sleep and protein are the 2 variables that the majority have an effect on muscle protein synthesis. Each are inside your management.
Vitamin
- Protein goal: 1.6 to 2.2g/kg/day: For a 90kg individual, that is 144 to 198g. Construct each meal round a protein anchor first.
- Don’t over-restrict energy: GLP-1 medicines already scale back consumption considerably. Including aggressive extra restriction accelerates lean mass loss with out enhancing fats loss proportionally. Let the remedy do the work.
- Protein shakes are a legit instrument: On days when urge for food may be very low, a protein shake is among the best methods to hit protein targets with out requiring the urge for food for a full meal.
Monitoring
- DEXA or physique composition monitoring: The size alone doesn’t distinguish fats from muscle. If physique composition issues to you, a DEXA scan at baseline and periodically by means of therapy provides the precise image. Many gyms and well being facilities provide this at a low value.
- Efficiency as a proxy: In case your power coaching efficiency (masses, reps) is maintained or enhancing, your muscle is basically intact. If it drops considerably regardless of enough protein and restoration, it’s price reviewing your diet targets.
Regularly requested questions
Do GLP-1 medicines trigger muscle loss?
Some lean mass loss happens with any vital weight reduction, together with on GLP-1 medicines. Within the SURMOUNT-1 DXA substudy, 25% of weight misplaced on tirzepatide was lean mass and 75% was fats.
This proportion is per different weight reduction interventions, together with bariatric surgical procedure and calorie restriction. GLP-1 medicines don’t trigger disproportionate lean mass loss. Resistance coaching and enough protein consumption scale back the proportion of lean mass misplaced.
Is Mounjaro or Wegovy higher for muscle preservation?
Tirzepatide (Mounjaro) produces a decrease proportional lean mass loss than semaglutide (Wegovy): roughly 25-26% of weight misplaced as lean mass versus roughly 40% with semaglutide.
Nevertheless, as a result of tirzepatide drives larger whole weight reduction, absolutely the quantity of lean mass misplaced could also be greater for some customers.
A big 2026 real-world evaluation confirmed larger relative LBM loss with tirzepatide in any respect measured time factors. For lively people who find themselves already lean and anxious about absolute lean mass, this nuance is price factoring into the selection between medicines with a prescriber.
Are you able to construct muscle whereas on Mounjaro?
Muscle hypertrophy (web muscle acquire) is troublesome throughout a calorie deficit, and GLP-1 therapy sometimes includes a calorie deficit. The achievable goal is lean mass preservation: ending therapy with the identical absolute muscle mass you began with, despite the fact that whole physique weight is decrease.
With resistance coaching at two or extra periods per week and protein at 1.6 to 2.2g/kg/day, that is achievable. After therapy, or throughout a upkeep section, constructing muscle follows regular ideas with out the complication of a big calorie deficit.
What protein consumption is required on GLP-1 medicines?
Throughout lively weight reduction, the American Journal of Medical Vitamin recommends 1.2 to 1.6g of protein per kg physique weight per day. For lively individuals doing resistance coaching, the proof helps 1.6 to 2.2g/kg/day.
The sensible problem of GLP-1 therapy is that decreased urge for food could make hitting protein targets troublesome. Constructing meals protein-first and utilizing protein shakes on low-appetite days are the best methods.
How does retatrutide evaluate to Mounjaro for lean mass?
Part 2 retatrutide knowledge present lean mass loss proportions much like tirzepatide and semaglutide, regardless of larger whole weight reduction. The glucagon receptor activation in retatrutide theoretically helps preferential fats oxidation, however head-to-head physique composition knowledge evaluating retatrutide on to tirzepatide haven’t but been revealed.
Part 3 TRIUMPH trial knowledge, anticipated to be accomplished in 2026, will present extra detailed physique composition outcomes. Voy has revealed a evaluate of the present retatrutide physique composition knowledge on the hyperlink above.
This text is for informational functions solely and doesn’t represent medical recommendation. All the time seek the advice of a certified healthcare skilled earlier than beginning any weight reduction therapy. Particular person outcomes could differ. Therapy is topic to scientific suitability evaluation.
References
- Look M et al. Physique composition modifications throughout weight discount with tirzepatide within the SURMOUNT-1 research of adults with weight problems or obese. Diabetes, Weight problems and Metabolism, 2025. pmc.ncbi.nlm.nih.gov/articles/PMC11965027/
- PMC case sequence. Preservation of lean smooth tissue throughout weight reduction induced by GLP-1 and GLP-1/GIP receptor agonists. SAGE Open Drugs, 2025. pmc.ncbi.nlm.nih.gov/articles/PMC12536186/
- Hidalgo Ramos et al. Results of Tirzepatide on Skeletal Muscle Mass in Adults: A Systematic Assessment. PMC, 2025. pmc.ncbi.nlm.nih.gov/articles/PMC12394919/
- Venkatakrishnan AJ et al. Larger lean-body-mass decline with tirzepatide than semaglutide in routine care. medRxiv, April 2026. medrxiv.org/content material/10.64898/2026.04.11.26350687v1.full
- Aronne LJ et al. Tirzepatide as In contrast with Semaglutide for the Therapy of Weight problems. SURMOUNT-5. New England Journal of Drugs, 2025.
- Leidy HJ et al. The position of protein in weight reduction and upkeep. American Journal of Medical Vitamin, 2015. ajcn.diet.org/article/S0002-9165(23)27427-4/fulltext
- Jastreboff AM et al. Retatrutide, a GIP, GLP-1, and Glucagon Receptor Agonist, for Weight problems. Part 2 trial. New England Journal of Drugs, 2023.
- Voy. Retatrutide fats loss vs muscle loss: what the information exhibits. joinvoy.com/weblog/retatrutide-fat-loss-vs-muscle-loss
